Behavioral Neuroscience – News and Features

Here, we highlight some of the latest advancements in vitamin A research working to address its effects on human health.

Rice University engineers have developed the smallest implantable brain stimulator demonstrated in a human patient. Thanks to magnetoelectric power transfer technology, the pea-sized device can be powered wirelessly.

A single low dose of esketamine – the active form of the anesthetic drug, ketamine – can reduce depressive episodes when given immediately after childbirth, a new study has found.

Research suggests that with exercise, we have a natural way to improve immune health. Recent studies have advanced our understanding of the molecular processes that underpin exercise immunology.

Inside the brains of people with psychosis, two key systems are malfunctioning: a “filter” that directs attention toward important events and thoughts, and a “predictor” composed of pathways that anticipate rewards.

A research team has added to evidence that a chemical found naturally in cannabis can, in the right amounts, lessen the anxiety-inducing effects of tetrahydrocannabinol (THC), the primary psychoactive sister chemical found in cannabis.

Columbia researchers have discovered a genetic variant that reduces the odds of developing Alzheimer’s disease by up to 70% and may be protecting thousands of people in the United States from the disease.

Now, researchers from Japan have developed an animal model and elucidated the mechanism by which mutation in genes involved in chromatin modification causes autism. They have also discovered a drug that can be used in the treatment of autism.

Investigators at Weill Cornell Medicine have assembled the most comprehensive atlas to date of messenger RNA (mRNA) variants in the mouse and human brain.

New research has shown how blocking the activity of the Tiam1 enzyme in certain spinal neurons could reduce morphine tolerance and prolong the usefulness of morphine for pain relief.